Please login or register first to view this content.
Dermatological Disorders Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
Zoryve Cream Now Available for Plaque Psoriasis
Companies Selling Unapproved Drugs for Mole, Skin Tag Removal Get FDA Warning Letter
July 2022: Notable Drug Approvals
Juvéderm Volux XC Approved for Improving Jawline Definition
FDA to Review Resubmitted Application for Severe Burn Therapy NexoBrid
Study Investigating Oral JAK Inhibitor for Alopecia Areata Meets Endpoint
Zoryve Cream Approved for Plaque Psoriasis
Banana Boat Sunscreen Recalled Due to Benzene
Opzelura Cream Approved for Nonsegmental Vitiligo
June 2022: Notable Drug Approvals
Vilobelimab Fast Tracked for Ulcerative Pyoderma Gangrenosum
Rise in Cost of Biologics for Psoriasis Outpacing Medical Inflation
Experts Address Lab Monitoring of Isotretinoin for Treating Acne
Olumiant Approved for Severe Alopecia Areata
Dupixent Approved for Atopic Dermatitis in Younger Pediatric Patients
Improvements in Skin Clearance Maintained With Lebrikizumab in Atopic Dermatitis Trials
Roflumilast Foam Looks Promising in Seborrheic Dermatitis Trial
Lotion, Cream, Gel, and Ointment Similarly Effective for Childhood Eczema
